ArticleBMC pulmonary medicine2020

Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.

Takumi Yoshikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.